Jeffrey Dayno is President and Chief Executive Officer of Harmony Biosciences Holdings, Inc. (HRMY). The company reported total compensation of $7,899,535 for fiscal year 2025.
| Salary | $743,600 |
|---|---|
| Bonus | $0 |
| Stock awards | $1,976,520 |
| Option awards | $4,599,000 |
| Non-equity incentive plan | $558,000 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $22,415 |
| Total | $7,899,535 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Harmony Biosciences Holdings, Inc. filed April 3, 2026, accession 0001104659-26-039449.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Jeffrey Dayno this page | President and Chief Executive Officer | $7,899,535 |
| Adam Zaeske | Executive Vice President and Chief Commercial Officer | $3,664,228 |
| Sandip Kapadia | Executive Vice President, Chief Financial Officer and Chief Administrative Officer | $3,204,319 |
| Jeffrey Dierks | Former Executive Vice President and Chief Commercial Officer | $2,346,945 |
| Kumar Budur | Executive Vice President and Chief Medical and Scientific Officer | $2,279,439 |
| Andrew Serafin | Executive Vice President and Chief Strategy Officer | $2,009,277 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Harmony Biosciences Holdings, Inc. compensation brief.
Jeffrey Dayno's compensation sits inside Harmony Biosciences Holdings, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.
The Harmony Biosciences Holdings, Inc. (HRMY) compensation brief